Submit Deal

Alan Colowick

Managing Director at MATRIX CAPITAL MANAGEMENT

Investor

Deal Bio

Total Deals4

Valued Deals4

Total Value£5,287M

Avg. Deal Size£1,322M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (4)

Sort

United States

Pharmaceuticals

MajorityAcquisitionPublicTender OfferCross Border

target

Principia Biopharma

bidder

Sanofi

£2,750m

35 dealmakers

United States

Biotechnology

Venture CapitalAcquisitionDomesticPrivateMajorityPrivate Equity

target

Velosbio

bidder

Merck & Co

£2,116m

55 dealmakers

United States

Pharmaceuticals

Private EquityVenture CapitalPrivateCross BorderMinorityAcquisition

target

Recode Therapeutics

bidder

Mpm Capital

£163m

6 dealmakers

United States

Biotechnology

MinorityAcquisitionPrivatePrivate EquityVenture CapitalCross Border

target

ACELYRIN

bidder

Westlake Village Biopartners

£257m

11 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy